Amino acid replacement: R1687C.
C17041321T
R1687C | RhoGEF2-PD; R1333C | RhoGEF2-PE; R1687C | RhoGEF2-PF; R1685C | RhoGEF2-PG; R1584C | RhoGEF2-PH
R1687C
Site of nucleotide substitution in mutant inferred by FlyBase based on reported amino acid change.
RhoGEF26.5/RhoGEF24.1 animals show 60% embryonic viability, 6% first larval instar viability and 0% adult viability. Salivary gland cells are not internalised in RhoGEF26.5/RhoGEF24.1 embryos, but remain on the surface (in contrast to wild-type embryos). Muscle and neuronal tissues show no significant defects in gross morphology in late-stage RhoGEF26.5/RhoGEF24.1 embryos.
RhoGEF26.5 is a suppressor of visible phenotype of Rho1GMR.PH
RhoGEF26.5, fog4/fog[+] has visible phenotype
RhoGEF26.5/RhoGEF2[+], fog4 has visible | dominant phenotype
RhoGEF26.5 is a suppressor of eye phenotype of Rho1GMR.PH
RhoGEF26.5, fog4 has wing phenotype
RhoGEF26.5/RhoGEF2[+], fog4 has wing phenotype
16% of fog4/+ ; RhoGEF26.5/+ animals have wing defects.
Dominantly suppresses the Rho1GMR.PH rough eye phenotype.
Isolated as a dominant suppressor of the Rho1GMR.PH rough eye phenotype.